等待开盘 02-04 09:30:00 美东时间
-0.890
-2.09%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Citigroup analyst Andrew Kaplowitz maintains KBR (NYSE:KBR) with a Buy and lowers the price target from $57 to $53.
01-26 23:39
KBR (NYSE:KBR) has been awarded the front-end engineering design (FEED) contract for Coastal Bend's planned natural gas liquefaction and export facility on the Texas Gulf Coast.The Coastal Bend LNG project will feature
01-12 19:19
KBR (NYSE:KBR) announced today it has been awarded a Technical Support Services Contract (TSSC) by the U.S. Geological Survey (USGS), with a $350 million ceiling, to deliver advanced technical solutions for the Earth
01-05 19:08
今日重点评级关注:HC Wainwright & Co.:维持Pyxis Oncology"买入"评级,目标价从5美元升至7美元;Stifel:维持Oculis Holding"买入"评级,目标价从35美元升至40美元
2025-12-22 15:05
KBR (NYSE:KBR) announced today that it has been awarded a technology and engineering contract by IGNIS for a new green ammonia facility in A Coruña, Spain.Under the terms of the contract, KBR will provide proprietary
2025-12-15 19:06
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Oppenheimer analyst Ian Zaffino initiates coverage on KBR (NYSE:KBR) with a Outperform rating and announces Price Target of $60.
2025-12-02 23:39
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43